Physician profile
Ravinder Samra
NPI 1861475915
$954.42
in general payments reported to CMS, 2019-2025
12 companies · $17.88 in 2025
The $17.88 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $18.52 · 2021: $29.70 · 2022: $95.20 · 2023: $154 · 2024: $216 · 2025: $17.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295 · Education: $93.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.22 |
| Education | $93.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $166.27 | 2019-2021 | |
| Hologic Sales and Service, LLC | $144.23 | 2022-2024 | Acessa Provu System, Coolseal Generator |
| Intuitive Surgical, INC. | $131.72 | 2019 | |
| Astellas Pharma US INC | $110.71 | 2022-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $88.16 | 2019-2025 | |
| Therapeuticsmd, INC. | $70.35 | 2019 | |
| Exeltis, USA INC. | $66.04 | 2022-2024 | Slynd |
| Pfizer INC. | $51.50 | 2023-2024 | |
| Covidien Lp | $47.20 | 2019 | |
| Mindray Ds USA, INC. | $42.30 | 2024 | Te7 Max, Te X |
| Mallinckrodt Enterprises LLC | $19.63 | 2019 | |
| Organon LLC | $16.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravinder Samra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.